Tenaya Therapeutics (TNYA) Operating Leases (2021 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Operating Leases of $7.0 million for Q1 2026, down 30.79% year-over-year from $10.1 million in Q1 2025, and down 10.35% quarter-over-quarter from $7.8 million in Q4 2025.
Tenaya Therapeutics (TNYA) Operating Leases (2021 - 2026) Analysis & Trends
Tenaya Therapeutics' Operating Leases history runs 6 years deep, the most recent figure standing at $7.0 million for Q1 2026.
- In Q1 2026, Operating Leases fell 30.79% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (down 30.79% YoY), while the FY2025 annual figure was $7.8 million, down 27.89% from the prior year.
- Operating Leases for Q1 2026 stood at $7.0 million, down from $7.8 million in the prior quarter.
- The five-year high for Operating Leases was $13.1 million in Q2 2022, with the low at $7.0 million in Q1 2026.
- The 5-year median for Operating Leases is $10.1 million (2025), against an average of $10.1 million.
- The sharpest annual moves came in 2025 and 2026: Operating Leases soared 38.55% in 2025, then slumped 30.79% in 2026.
- Tenaya Therapeutics' Operating Leases stood at $11.1 million in 2022, then fell by 26.94% to $8.1 million in 2023, then surged by 33.62% to $10.8 million in 2024, then decreased by 27.89% to $7.8 million in 2025, then fell by 10.35% to $7.0 million in 2026.
- Business Quant data shows TNYA's Operating Leases at $7.0 million in Q1 2026, $7.8 million in Q4 2025, and $8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | Tenaya Therapeutics | 154.83 Mn | 154.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 7.81 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Jun 30, 2025 | 9.38 Mn |
| Mar 31, 2025 | 10.12 Mn |
| Dec 31, 2024 | 10.83 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | 12.21 Mn |
| Mar 31, 2024 | 7.30 Mn |
| Dec 31, 2023 | 8.11 Mn |
| Sep 30, 2023 | 8.89 Mn |
| Jun 30, 2023 | 9.66 Mn |
| Mar 31, 2023 | 10.39 Mn |
| Dec 31, 2022 | 11.09 Mn |
| Sep 30, 2022 | 12.04 Mn |
| Jun 30, 2022 | 13.10 Mn |
| Mar 31, 2022 | 13.09 Mn |
| Dec 31, 2021 | 13.71 Mn |
| Sep 30, 2021 | 14.31 Mn |